Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Chemical & Material > Recombinant Collagen-Based Biomaterial- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Recombinant Collagen-Based Biomaterial- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published: 2026-01-19

Pages: 100 Pages

Report ld: 5743334

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Collagen-Based Biomaterial cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.

Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.

This report provides a comprehensive view of the global market for Recombinant Collagen-Based Biomaterial, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Recombinant Collagen-Based Biomaterial market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Recombinant Collagen-Based Biomaterial.

Market Segmentation

Report Metric
Details
Report Title
Recombinant Collagen-Based Biomaterial- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Market Size Available for Years
2026-2032
Global Recombinant Collagen-Based Biomaterial Companies Covered
Evonik Industries
Trautec
Genemedicine
FibroGen
CollPlant
Geltor
Modern Meadow
Global Recombinant Collagen-Based Biomaterial Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Collagen-Based Biomaterial Market, Segment by Type
Medical Grade Recombinant Collagen
Cosmetic Grade Recombinant Collagen
Food Grade Recombinant Collagen
Others
Global Recombinant Collagen-Based Biomaterial Market, Segment by Application
Medical Industry
Cosmetic Industry
Food Industry
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Recombinant Collagen-Based Biomaterial manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Recombinant Collagen-Based Biomaterial sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Recombinant Collagen-Based Biomaterial sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Recombinant Collagen-Based Biomaterial Product Introduction
    1.2 Global Recombinant Collagen-Based Biomaterial Market Size Forecast
        1.2.1 Global Recombinant Collagen-Based Biomaterial Sales Value (2021–2032)
        1.2.2 Global Recombinant Collagen-Based Biomaterial Sales Volume (2021–2032)
        1.2.3 Global Recombinant Collagen-Based Biomaterial Sales Price (2021–2032)
    1.3 Recombinant Collagen-Based Biomaterial Market Trends & Drivers
        1.3.1 Recombinant Collagen-Based Biomaterial Industry Trends
        1.3.2 Recombinant Collagen-Based Biomaterial Market Drivers & Opportunities
        1.3.3 Recombinant Collagen-Based Biomaterial Market Challenges
        1.3.4 Recombinant Collagen-Based Biomaterial Market Restraints
        1.3.5 Impact of U.S. Tariffs
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Recombinant Collagen-Based Biomaterial Players Revenue Ranking (2025)
    2.2 Global Recombinant Collagen-Based Biomaterial Revenue by Company (2021–2026)
    2.3 Global Recombinant Collagen-Based Biomaterial Sales Volume Ranking of Players (2025)
    2.4 Global Recombinant Collagen-Based Biomaterial Sales Volume by Company (2021–2026)
    2.5 Global Recombinant Collagen-Based Biomaterial Average Price by Company (2021–2026)
    2.6 Key Manufacturers Recombinant Collagen-Based Biomaterial Manufacturing Base and Headquarters
    2.7 Key Manufacturers Recombinant Collagen-Based Biomaterial Product Offerings
    2.8 Key Manufacturers Start of Mass Production of Recombinant Collagen-Based Biomaterial
    2.9 Recombinant Collagen-Based Biomaterial Market Competitive Analysis
        2.9.1 Recombinant Collagen-Based Biomaterial Market Concentration Rate (2021–2026)
        2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Collagen-Based Biomaterial Revenue in 2025
        2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Collagen-Based Biomaterial revenue, 2025
    2.10 Mergers & Acquisitions and Expansion

3 Segmentation Recombinant Collagen-Based Biomaterial Market Classification
    3.1 Introduction by Type
        3.1.1 Medical Grade Recombinant Collagen
        3.1.2 Cosmetic Grade Recombinant Collagen
        3.1.3 Food Grade Recombinant Collagen
        3.1.4 Others
        3.1.5 Global Recombinant Collagen-Based Biomaterial Sales Value by Type
            3.1.5.1 Global Recombinant Collagen-Based Biomaterial Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.5.2 Global Recombinant Collagen-Based Biomaterial Sales Value, by Type (2021–2032)
            3.1.5.3 Global Recombinant Collagen-Based Biomaterial Sales Value, by Type (%), 2021–2032
        3.1.6 Global Recombinant Collagen-Based Biomaterial Sales Volume by Type
            3.1.6.1 Global Recombinant Collagen-Based Biomaterial Sales Volume by Type (2021 vs 2025 vs 2032)
            3.1.6.2 Global Recombinant Collagen-Based Biomaterial Sales Volume, by Type (2021–2032)
            3.1.6.3 Global Recombinant Collagen-Based Biomaterial Sales Volume, by Type (%), 2021–2032
        3.1.7 Global Recombinant Collagen-Based Biomaterial Average Price by Type (2021–2032)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Medical Industry
        4.1.2 Cosmetic Industry
        4.1.3 Food Industry
        4.1.4 Others
    4.2 Global Recombinant Collagen-Based Biomaterial Sales Value by Application
        4.2.1 Global Recombinant Collagen-Based Biomaterial Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Recombinant Collagen-Based Biomaterial Sales Value, by Application (2021–2032)
        4.2.3 Global Recombinant Collagen-Based Biomaterial Sales Value, by Application (%), 2021–2032
    4.3 Global Recombinant Collagen-Based Biomaterial Sales Volume by Application
        4.3.1 Global Recombinant Collagen-Based Biomaterial Sales Volume by Application (2021 vs 2025 vs 2032)
        4.3.2 Global Recombinant Collagen-Based Biomaterial Sales Volume, by Application (2021–2032)
        4.3.3 Global Recombinant Collagen-Based Biomaterial Sales Volume, by Application (%), 2021–2032
    4.4 Global Recombinant Collagen-Based Biomaterial Average Price by Application (2021–2032)

5 Segmentation by Region
    5.1 Global Recombinant Collagen-Based Biomaterial Sales Value by Region
        5.1.1 Global Recombinant Collagen-Based Biomaterial Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Recombinant Collagen-Based Biomaterial Sales Value by Region (2021–2026)
        5.1.3 Global Recombinant Collagen-Based Biomaterial Sales Value by Region (2027–2032)
        5.1.4 Global Recombinant Collagen-Based Biomaterial Sales Value by Region (%), 2021–2032
    5.2 Global Recombinant Collagen-Based Biomaterial Sales Volume by Region
        5.2.1 Global Recombinant Collagen-Based Biomaterial Sales Volume by Region: 2021 vs 2025 vs 2032
        5.2.2 Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (2021–2026)
        5.2.3 Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (2027–2032)
        5.2.4 Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (%), 2021–2032
    5.3 Global Recombinant Collagen-Based Biomaterial Average Price by Region (2021–2032)
    5.4 North America
        5.4.1 North America Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        5.4.2 North America Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032
    5.5 Europe
        5.5.1 Europe Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        5.5.2 Europe Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032
    5.6 Asia Pacific
        5.6.1 Asia Pacific Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        5.6.2 Asia Pacific Recombinant Collagen-Based Biomaterial Sales Value by Region (%), 2025 vs 2032
    5.7 South America
        5.7.1 South America Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        5.7.2 South America Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        5.8.2 Middle East & Africa Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Value and Sales Volume
        6.2.1 Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.2.2 Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Volume, 2021–2032
    6.3 United States
        6.3.1 United States Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.3.2 United States Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Recombinant Collagen-Based Biomaterial Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.4.2 Europe Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Recombinant Collagen-Based Biomaterial Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.5.2 China Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Recombinant Collagen-Based Biomaterial Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.6.2 Japan Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Recombinant Collagen-Based Biomaterial Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.7.2 South Korea Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Recombinant Collagen-Based Biomaterial Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.8.2 Southeast Asia Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Recombinant Collagen-Based Biomaterial Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Recombinant Collagen-Based Biomaterial Sales Value, 2021–2032
        6.9.2 India Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Recombinant Collagen-Based Biomaterial Sales Value by Application, 2025 vs 2032

7 Company Profiles
    7.1 Evonik Industries
        7.1.1 Evonik Industries Company Information
        7.1.2 Evonik Industries Introduction and Business Overview
        7.1.3 Evonik Industries Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
        7.1.4 Evonik Industries Recombinant Collagen-Based Biomaterial Product Offerings
        7.1.5 Evonik Industries Recent Developments
    7.2 Trautec
        7.2.1 Trautec Company Information
        7.2.2 Trautec Introduction and Business Overview
        7.2.3 Trautec Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
        7.2.4 Trautec Recombinant Collagen-Based Biomaterial Product Offerings
        7.2.5 Trautec Recent Developments
    7.3 Genemedicine
        7.3.1 Genemedicine Company Information
        7.3.2 Genemedicine Introduction and Business Overview
        7.3.3 Genemedicine Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
        7.3.4 Genemedicine Recombinant Collagen-Based Biomaterial Product Offerings
        7.3.5 Genemedicine Recent Developments
    7.4 FibroGen
        7.4.1 FibroGen Company Information
        7.4.2 FibroGen Introduction and Business Overview
        7.4.3 FibroGen Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
        7.4.4 FibroGen Recombinant Collagen-Based Biomaterial Product Offerings
        7.4.5 FibroGen Recent Developments
    7.5 CollPlant
        7.5.1 CollPlant Company Information
        7.5.2 CollPlant Introduction and Business Overview
        7.5.3 CollPlant Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
        7.5.4 CollPlant Recombinant Collagen-Based Biomaterial Product Offerings
        7.5.5 CollPlant Recent Developments
    7.6 Geltor
        7.6.1 Geltor Company Information
        7.6.2 Geltor Introduction and Business Overview
        7.6.3 Geltor Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
        7.6.4 Geltor Recombinant Collagen-Based Biomaterial Product Offerings
        7.6.5 Geltor Recent Developments
    7.7 Modern Meadow
        7.7.1 Modern Meadow Company Information
        7.7.2 Modern Meadow Introduction and Business Overview
        7.7.3 Modern Meadow Recombinant Collagen-Based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
        7.7.4 Modern Meadow Recombinant Collagen-Based Biomaterial Product Offerings
        7.7.5 Modern Meadow Recent Developments

8 Industry Chain Analysis
    8.1 Recombinant Collagen-Based Biomaterial Industrial Chain
    8.2 Recombinant Collagen-Based Biomaterial Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customer Analysis)
    8.5 Sales Model and Sales Channelss
        8.5.1 Recombinant Collagen-Based Biomaterial Sales Model
        8.5.2 Sales Channels
        8.5.3 Recombinant Collagen-Based Biomaterial Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Recombinant Collagen-Based Biomaterial Market Trends
 Table 2. Recombinant Collagen-Based Biomaterial Market Drivers & Opportunities
 Table 3. Recombinant Collagen-Based Biomaterial Market Challenges
 Table 4. Recombinant Collagen-Based Biomaterial Market Restraints
 Table 5. Global Recombinant Collagen-Based Biomaterial Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Company (2021–2026)
 Table 7. Global Recombinant Collagen-Based Biomaterial Sales Volume by Company (Tons), 2021–2026
 Table 8. Global Recombinant Collagen-Based Biomaterial Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Recombinant Collagen-Based Biomaterial Price by Company (US$/Ton), 2021–2026
 Table 10. Key Manufacturers Recombinant Collagen-Based Biomaterial Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Recombinant Collagen-Based Biomaterial Product Type
 Table 12. Key Manufacturers Start of Mass Production of Recombinant Collagen-Based Biomaterial
 Table 13. Global Recombinant Collagen-Based Biomaterial Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Collagen-Based Biomaterial revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Recombinant Collagen-Based Biomaterial Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Recombinant Collagen-Based Biomaterial Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Recombinant Collagen-Based Biomaterial Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Recombinant Collagen-Based Biomaterial Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Recombinant Collagen-Based Biomaterial Sales Volume by Type (Tons), 2021–2026
 Table 23. Global Recombinant Collagen-Based Biomaterial Sales Volume by Type (Tons), 2027–2032
 Table 24. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Recombinant Collagen-Based Biomaterial Price by Type (US$/Ton), 2021–2026
 Table 27. Global Recombinant Collagen-Based Biomaterial Price by Type (US$/Ton), 2027–2032
 Table 28. Global Recombinant Collagen-Based Biomaterial Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Recombinant Collagen-Based Biomaterial Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Recombinant Collagen-Based Biomaterial Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Recombinant Collagen-Based Biomaterial Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
 Table 34. Global Recombinant Collagen-Based Biomaterial Sales Volume by Application (Tons), 2021–2026
 Table 35. Global Recombinant Collagen-Based Biomaterial Sales Volume by Application (Tons), 2027–2032
 Table 36. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Recombinant Collagen-Based Biomaterial Price by Application (US$/Ton), 2021–2026
 Table 39. Global Recombinant Collagen-Based Biomaterial Price by Application (US$/Ton), 2027–2032
 Table 40. Global Recombinant Collagen-Based Biomaterial Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Recombinant Collagen-Based Biomaterial Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Recombinant Collagen-Based Biomaterial Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Recombinant Collagen-Based Biomaterial Sales Value by Region (%), 2021–2026
 Table 44. Global Recombinant Collagen-Based Biomaterial Sales Value by Region (%), 2027–2032
 Table 45. Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
 Table 46. Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (Tons), 2021–2026
 Table 47. Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (Tons), 2027–2032
 Table 48. Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (%), 2021–2026
 Table 49. Global Recombinant Collagen-Based Biomaterial Sales Volume by Region (%), 2027–2032
 Table 50. Global Recombinant Collagen-Based Biomaterial Average Price by Region (US$/Ton), 2021–2026
 Table 51. Global Recombinant Collagen-Based Biomaterial Average Price by Region (US$/Ton), 2027–2032
 Table 52. Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Volume, (Tons), 2021–2026
 Table 56. Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Volume, (Tons), 2027–2032
 Table 57. Evonik Industries Company Information
 Table 58. Evonik Industries Introduction and Business Overview
 Table 59. Evonik Industries Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 60. Evonik Industries Recombinant Collagen-Based Biomaterial Product Offerings
 Table 61. Evonik Industries Recent Developments
 Table 62. Trautec Company Information
 Table 63. Trautec Introduction and Business Overview
 Table 64. Trautec Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 65. Trautec Recombinant Collagen-Based Biomaterial Product Offerings
 Table 66. Trautec Recent Developments
 Table 67. Genemedicine Company Information
 Table 68. Genemedicine Introduction and Business Overview
 Table 69. Genemedicine Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 70. Genemedicine Recombinant Collagen-Based Biomaterial Product Offerings
 Table 71. Genemedicine Recent Developments
 Table 72. FibroGen Company Information
 Table 73. FibroGen Introduction and Business Overview
 Table 74. FibroGen Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 75. FibroGen Recombinant Collagen-Based Biomaterial Product Offerings
 Table 76. FibroGen Recent Developments
 Table 77. CollPlant Company Information
 Table 78. CollPlant Introduction and Business Overview
 Table 79. CollPlant Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 80. CollPlant Recombinant Collagen-Based Biomaterial Product Offerings
 Table 81. CollPlant Recent Developments
 Table 82. Geltor Company Information
 Table 83. Geltor Introduction and Business Overview
 Table 84. Geltor Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 85. Geltor Recombinant Collagen-Based Biomaterial Product Offerings
 Table 86. Geltor Recent Developments
 Table 87. Modern Meadow Company Information
 Table 88. Modern Meadow Introduction and Business Overview
 Table 89. Modern Meadow Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 90. Modern Meadow Recombinant Collagen-Based Biomaterial Product Offerings
 Table 91. Modern Meadow Recent Developments
 Table 92. Key Raw Materials Lists
 Table 93. Key Suppliers of Raw Materials Lists
 Table 94. Recombinant Collagen-Based Biomaterial Downstream Customers
 Table 95. Recombinant Collagen-Based Biomaterial Distributors List
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Collagen-Based Biomaterial Product Picture
 Figure 2. Global Recombinant Collagen-Based Biomaterial Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 4. Global Recombinant Collagen-Based Biomaterial Sales Volume (Tons), 2021–2032
 Figure 5. Global Recombinant Collagen-Based Biomaterial Sales Price (US$/Ton), 2021–2032
 Figure 6. Recombinant Collagen-Based Biomaterial Report Years Considered
 Figure 7. Global Recombinant Collagen-Based Biomaterial Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Recombinant Collagen-Based Biomaterial Sales Volume Ranking of Players (Tons), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Collagen-Based Biomaterial Revenue in 2025
 Figure 10. Recombinant Collagen-Based Biomaterial Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Medical Grade Recombinant Collagen Picture
 Figure 12. Cosmetic Grade Recombinant Collagen Picture
 Figure 13. Food Grade Recombinant Collagen Picture
 Figure 14. Others Picture
 Figure 15. Global Recombinant Collagen-Based Biomaterial Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Recombinant Collagen-Based Biomaterial Sales Value Market Share by Type, 2025 & 2032
 Figure 17. Global Recombinant Collagen-Based Biomaterial Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
 Figure 18. Global Recombinant Collagen-Based Biomaterial Sales Volume Market Share by Type, 2025 & 2032
 Figure 19. Global Recombinant Collagen-Based Biomaterial Price by Type (US$/Ton), 2021–2032
 Figure 20. Product Picture of Medical Industry
 Figure 21. Product Picture of Cosmetic Industry
 Figure 22. Product Picture of Food Industry
 Figure 23. Product Picture of Others
 Figure 24. Global Recombinant Collagen-Based Biomaterial Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 25. Global Recombinant Collagen-Based Biomaterial Sales Value Market Share by Application, 2025 & 2032
 Figure 26. Global Recombinant Collagen-Based Biomaterial Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
 Figure 27. Global Recombinant Collagen-Based Biomaterial Sales Volume Market Share by Application, 2025 & 2032
 Figure 28. Global Recombinant Collagen-Based Biomaterial Price by Application (US$/Ton), 2021–2032
 Figure 29. North America Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 30. North America Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 31. Europe Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 32. Europe Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 33. Asia Pacific Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 34. Asia Pacific Recombinant Collagen-Based Biomaterial Sales Value by Region (%), 2025 vs 2032
 Figure 35. South America Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 36. South America Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 37. Middle East & Africa Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 38. Middle East & Africa Recombinant Collagen-Based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 39. Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Value (%), 2021–2032
 Figure 40. Key Countries/Regions Recombinant Collagen-Based Biomaterial Sales Volume (%), 2021–2032
 Figure 41. United States Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 42. United States Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 43. United States Recombinant Collagen-Based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 44. Europe Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 45. Europe Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 46. Europe Recombinant Collagen-Based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 47. China Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 48. China Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 49. China Recombinant Collagen-Based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 50. Japan Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 51. Japan Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 52. Japan Recombinant Collagen-Based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 53. South Korea Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 54. South Korea Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 55. South Korea Recombinant Collagen-Based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 56. Southeast Asia Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 57. Southeast Asia Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 58. Southeast Asia Recombinant Collagen-Based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 59. India Recombinant Collagen-Based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 60. India Recombinant Collagen-Based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 61. India Recombinant Collagen-Based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 62. Recombinant Collagen-Based Biomaterial Industrial Chain
 Figure 63. Recombinant Collagen-Based Biomaterial Manufacturing Cost Structure
 Figure 64. Channels of Distribution (Direct Sales, and Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed

Description

The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Collagen-Based Biomaterial cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.

Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.

This report provides a comprehensive view of the global market for Recombinant Collagen-Based Biomaterial, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Recombinant Collagen-Based Biomaterial market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Recombinant Collagen-Based Biomaterial.

Market Segmentation

Related Reports

Global Recombinant Collagen-Based Biomaterial Market Insights, Forecast to 2030
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 139
USD 4900.00
(Single User License)
Global and United States Recombinant Collagen-Based Biomaterial Market Report & Forecast 2024-2030
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 120
USD 4350.00
(Single User License)
Global Recombinant Collagen-Based Biomaterial Market Research Report 2024
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 89
USD 2900.00
(Single User License)
Global Recombinant Collagen-Based Biomaterial Market Research Report 2025
The global market for Recombinant Collagen-Based Biomaterial was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 92
USD 2900.00
(Single User License)
Recombinant Collagen-Based Biomaterial - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
USD 3950.00
(Single User License)
Global Recombinant Collagen-Based Biomaterial Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 76
USD 4250.00
(Single User License)
Global Recombinant Collagen-Based Biomaterial Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 136
USD 4900.00
(Single User License)
Global Recombinant Collagen-Based Biomaterial Market Research Report 2026
The global Recombinant Collagen-Based Biomaterial market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 130
USD 2900.00
(Single User License)
Global Recombinant Collagen-Based Biomaterial Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 80
USD 4250.00
(Single User License)
Global Recombinant Collagen-Based Biomaterial Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 139
USD 4900.00
(Single User License)

Global Recombinant Collagen-Based Biomaterial Market Insights, Forecast to 2030
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 139
USD 4900.00 ()
Global and United States Recombinant Collagen-Based Biomaterial Market Report & Forecast 2024-2030
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 120
USD 4350.00 ()
Global Recombinant Collagen-Based Biomaterial Market Research Report 2024
Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
Published: 2024-06-07
Pages: 89
USD 2900.00 ()
Global Recombinant Collagen-Based Biomaterial Market Research Report 2025
The global market for Recombinant Collagen-Based Biomaterial was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 92
USD 2900.00 ()
Recombinant Collagen-Based Biomaterial - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Collagen-Based Biomaterial was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
USD 3950.00 ()
Global Recombinant Collagen-Based Biomaterial Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 76
USD 4250.00 ()
Global Recombinant Collagen-Based Biomaterial Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 136
USD 4900.00 ()
Global Recombinant Collagen-Based Biomaterial Market Research Report 2026
The global Recombinant Collagen-Based Biomaterial market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 130
USD 2900.00 ()
Global Recombinant Collagen-Based Biomaterial Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Collagen-Based Biomaterial market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 80
USD 4250.00 ()
Global Recombinant Collagen-Based Biomaterial Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 139
USD 4900.00 ()